Brief Title
Sonography and Haemophilia
Official Title
Self-conducted Sonographic Monitoring of the Target Joints in Patients With Severe Haemophilia
Brief Summary
The aim of this study is to evaluate the possibility of establishing a patient-based ultrasound monitoring of the knee (representing a target joint accessible with any hand) with a handheld device: The following questions will be answered: 1. What is necessary for the organisational implementation of a patient-based ultrasound monitoring in patients with haemophilia? 2. Is it possible to train patients with haemophilia to perform sonography of their target joints? 3. Does a patient-based ultrasound monitoring with a handheld device work in a home setting? 4. What is the quality of the patient's self-acquired ultrasound images? 5. Will the test persons be able to distinguish normal findings from (any) pathologic findings?
Study Type
Observational
Primary Outcome
Landmarks of the Hemophilia Early Arthropathy Detection with Ultrasound (HEAD-US) protocol - Anterior mid-sagittal ultrasound image
Condition
Sonography
Intervention
feasibility study
Study Arms / Comparison Groups
Adult patients with severe haemophilia A or B
Description:
Publications
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
Recruitment Information
Recruitment Status
Other
Estimated Enrollment
5
Start Date
September 21, 2020
Completion Date
December 31, 2021
Primary Completion Date
July 31, 2021
Eligibility Criteria
Inclusion Criteria: - Adult patients (≥ 18 years of age) suffering from severe haemophilia A or B - No professional medical background - Submitted written consent to participate in the study and to use their study related pseudonymized data Exclusion Criteria: - Patients suffering from other bleeding diseases - Participants < 18 years of age - Participants without written consent - Professional medical background
Gender
Male
Ages
18 Years - N/A
Accepts Healthy Volunteers
No
Contacts
Andreas Strauß, PD Dr., 004922828714176, [email protected]
Location Countries
Germany
Location Countries
Germany
Administrative Informations
NCT ID
NCT04550988
Organization ID
POD10816
Responsible Party
Principal Investigator
Study Sponsor
University Hospital, Bonn
Collaborators
Swedish Orphan Biovitrum
Study Sponsor
Andreas Strauß, PD Dr., Principal Investigator, Medicine of the University of Bonn
Verification Date
September 2020